Imdevimab (REGN10987) is a human monoclonal antibody designed specifically to target the SARS-CoV-2 virus responsible for COVID-19. Although it demonstrates limited efficacy against emerging COVID-19 variants, when used in conjunction with Casirivimab, Imdevimab has been shown to significantly reduce viral load and enhance disease outcomes. This combination therapy is pivotal for managing viral replication and improving patient response during treatment.
Imdevimab (REGN10987) is a human monoclonal antibody designed specifically to target the SARS-CoV-2 virus responsible for COVID-19. Although it demonstrates limited efficacy against emerging COVID-19 variants, when used in conjunction with Casirivimab, Imdevimab has been shown to significantly reduce viral load and enhance disease outcomes. This combination therapy is pivotal for managing viral replication and improving patient response during treatment.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
